Core Viewpoint - Kangda Foods announced that its stock will resume trading on October 24, following a share purchase agreement signed by Mr. Gao Sishi through his wholly-owned Hong Kong Shengyuan Holdings Limited, to acquire approximately 54.69% of the company's shares at a price of HKD 0.265 per share, totaling HKD 65.6426 million. Mr. Gao believes this acquisition will bring long-term growth opportunities for the company and plans to support sustainable development through channel expansion and technology upgrades [1]. Summary by Categories - **Acquisition Details** - Mr. Gao Sishi's company will acquire about 54.69% of Kangda Foods' shares at HKD 0.265 per share [1] - The total consideration for the acquisition amounts to HKD 65.6426 million [1] - **Future Plans** - Mr. Gao aims to bring long-term growth opportunities to Kangda Foods [1] - Plans include channel expansion and technology upgrades to support the company's sustainable development [1]

Core Viewpoint - Kangda Foods (00834.HK) announced that its shares will resume trading today, October 24, 2025 [1] Company Summary - Kangda Foods' shares will be available for trading starting at 9:00 AM on October 24, 2025 [1]

Core Viewpoint - 康大食品 (00834) has entered into a conditional share purchase agreement with Hong Kong Shengyuan Holdings Limited, where the seller agrees to sell approximately 248 million shares, representing about 54.69% of the total issued shares, for a total cash consideration of HKD 65.6426 million, equating to HKD 0.265 per share [1][2]. Group 1: Share Purchase Agreement - The seller has conditionally agreed to sell approximately 248 million shares, which is about 54.69% of the total issued shares, to the buyer for a total cash consideration of HKD 65.6426 million [1]. - Following the completion of the first batch of share sales, the buyer will hold approximately 241 million shares, representing about 53.15% of the total issued shares [1]. - After all share sales are completed, the buyer will hold approximately 248 million shares, representing about 54.69% of the total issued shares [1]. Group 2: Offer Details - According to Rule 26.1 of the Takeover Code, upon completion of the first batch of share sales, the buyer must make an unconditional mandatory cash offer for all issued shares at HKD 0.265 per share, which is a premium of approximately 16.23% over the last closing price of HKD 0.228 [2]. - The buyer's main business is investment holding, and the offer is fully owned by Mr. Gao, who is also the sole director of the buyer [2]. - Mr. Gao believes that this acquisition presents a highly attractive investment return opportunity for the company's long-term growth, leveraging his 40 years of experience in the food industry [2]. Group 3: Market Resumption - The company has applied to the Stock Exchange of Hong Kong and the Singapore Stock Exchange to resume trading of its shares starting from October 24, 2025, at 9:00 AM [3].

Major Events - Minglue Technology (02718) plans to offer 7.219 million Class A shares globally from October 23 to October 28, with cornerstone subscriptions amounting to $59 million [1] - Wisco Properties (00230) received a privatization offer from Wisco Hong Kong at a premium of approximately 104.08%, with trading resuming on October 24 [1] - Junyu Foundation (01757) was acquired by China Venture Capital Holdings for 75% of its shares at a discount of about 79.06%, with trading resuming on October 24 [1] - Kangda Foods (00834) was acquired by Gaosi Shi for approximately 54.69% of the company’s shares at a premium of about 16.23%, with trading resuming on October 24 [1] - Hutchison China MediTech (00013) presented data on HMPL-A251 at the AACR-NCI-EORTC International Conference on Molecular Targeted and Cancer Therapeutics [1] - Giant Bio (02367) received a medical device registration certificate for its Type I α1 collagen lyophilized fiber product [1] - Yiming Anke-B (01541) completed the first patient dosing in the Phase IB/II clinical trial of IMM2510 combined with IMM01 [1] - Heng Rui Medicine (01276) received approval to conduct clinical trials for injection of Rikan Trastuzumab [1] - Hansoh Pharmaceutical (03692) had its application for HS-10365 capsule marketing approval accepted by the National Medical Products Administration [1] - Baixin An-B (02185) completed market access and the first commercial surgery for the IBERIS® RDN system in Switzerland [1] - Haotian International Construction Investment (01341) purchased a total of 646 units of Ethereum as of October 23 [1] Share Buybacks/Reductions - Cornerstone Pharmaceuticals-B (02616) saw CEO Yang Jianxin and senior management purchase an additional 1 million shares [2] - Midea Group (00300) repurchased 1.3434 million A shares for approximately 99.998 million yuan on October 23 [2] - China Communications Construction (01800) repurchased 119.45 million A shares for approximately 10.5994 million yuan on October 23 [2] - Mengniu Dairy (02319) repurchased 700,000 shares for approximately 10.0692 million HKD on October 23 [2] - Lianlian Digital (02598) spent about 7.5555 million HKD to repurchase 967,000 shares on October 23 [2] - Lianyi Rong Technology-W (09959) repurchased 2.47 million shares for approximately 7.4137 million HKD on October 23 [2] - Heng Rui Medicine (01276) repurchased 97,500 A shares for approximately 6.2808 million yuan on October 23 [2] - Gushengtang (02273) repurchased 19,860 shares for approximately 5.8634 million HKD on October 23 [2] Operating Performance - Ping An Good Doctor (01833) reported total revenue of approximately 3.725 billion yuan for the first three quarters, a year-on-year increase of 13.6%, and plans to continue expanding AI technology to enhance medical service efficiency and quality [2] - Sands China Ltd. (01928) reported a 7.5% year-on-year increase in net revenue to $1.9 billion for the third quarter [2] - Livzon Pharmaceutical (01513) announced a net profit attributable to shareholders of 1.754 billion yuan for the first three quarters, a year-on-year increase of 4.86% [2] - China Railway Construction (01186) signed new contracts totaling 1.518765 trillion yuan in the first three quarters, a year-on-year increase of 3.08% [2] - Prada (01913) reported net revenue of 4.07 billion euros for the first three quarters, a year-on-year increase of 9% [2] Additional Performance Metrics - Baio Family Interactive (02100) reported 10.2 million active accounts in the third quarter, a year-on-year increase of 37.8% [3] - Anton Oilfield Services (03337) secured new orders worth 1.273 billion yuan in the third quarter [3]

Core Viewpoint - The acquisition agreement between 康大食品 (Kangda Food) and Hong Kong Shengyuan Holdings Limited involves the sale of approximately 248 million shares, representing about 54.69% of the total issued shares, for a total cash consideration of HKD 65.6426 million, equating to HKD 0.265 per share, which is a premium of approximately 16.23% over the last trading price [1][2]. Group 1 - The seller has conditionally agreed to sell and the buyer has conditionally agreed to purchase approximately 248 million shares, which is the entirety of the seller's holdings in the company [1]. - Following the completion of the first batch of share sales, the buyer will hold approximately 241 million shares, representing about 53.15% of the total issued shares [1]. - The total consideration was determined through fair negotiations considering the group's business, past financial performance, and stock liquidity [1]. Group 2 - Upon completion of the first batch of share sales, the buyer is required to make an unconditional mandatory cash offer for all issued shares, excluding those already owned or agreed to be acquired by the buyer and its concert parties [2]. - The buyer's main business is investment holding, and the acquisition is expected to bring significant benefits to the company, including increased capital injection, expanded sales channels, upgraded product technology, and integration of domestic and international market resources [2]. - The buyer, Mr. Gao, has 40 years of experience in the food industry and is the sole director of the buyer [2]. Group 3 - The company has applied to the Stock Exchange of Hong Kong and the Singapore Stock Exchange to resume trading of its shares starting from October 24, 2025 [3].

Core Viewpoint - 康大食品 announced a share purchase agreement where 鼎希有限公司 will sell 247,708,066 shares, representing approximately 54.69% of the total issued shares, to 香港盛源控股有限公司 for a total cash consideration of HKD 65,642,637.49, equating to HKD 0.265 per share, which is a premium of about 16.23% over the last closing price of HKD 0.228 [1] Group 1 - The share purchase agreement is set to be executed on October 18, 2025, with the buyer acquiring all shares held by the seller [1] - Following the completion of the first batch of shares, the buyer will hold 240,748,400 shares, approximately 53.15% of the total issued shares [1] - Upon completion of all share sales, the buyer will own 247,708,066 shares, approximately 54.69% of the total issued shares [1] Group 2 - According to the takeover code rule 26.1, the buyer must make an unconditional mandatory cash offer for all issued shares upon completion of the first batch of sales [2] - The buyer is a company registered in Hong Kong on May 14, 2025, primarily engaged in investment holding [2] - The company has applied to resume trading of its shares on the Hong Kong Stock Exchange and Singapore Stock Exchange starting from October 24, 2025 [2]

香港交易及結算所有限公司、香港聯合交易所有限公司及新加坡證券交易所 有限公司對本聯合公告的內容概不負責，對其準確性或完整性亦不發表任何 聲明，並明確表示概不就因本聯合公告全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 本聯合公告僅供參考，並不構成收購、購買或認購本公司證券之邀請或要約， 亦不構成在任何司法權區內的任何投票或批准的招攬，亦不得在違反適用法 律或法規的情況下在任何司法權區內出售、發行或轉讓本公司的證券。 本聯合公告不會在構成違反任何司法權區之適用法律或法規之情況下於或向 該司法權區全部或部分發佈、刊發或派發。 Hong Kong Sheng Yuan Holding Co., Limited 香港盛源控股有限公司 CHINA KANGDA FOOD COMPANY LIMITED 中國康大食品有限公 司 （於百慕達註冊成立的有限公司） （香港股份代號（第一上市）：834） （新加坡股份代號（第二上市）：P74） （於香港註冊成立的有限公司） 聯合公告 (1)要約人與賣方訂立有關本公司 已發行股份總數約54.69%的購股協議 (2)由德林證券（香港）有限公司代表要約人 提出 ...

Core Viewpoint - 康大食品 announced a temporary suspension of trading on the Hong Kong Stock Exchange starting at 9 AM today [1] Company Summary - 康大食品 will halt trading for a short period, indicating potential developments or announcements that may require market attention [1]

Core Points - 康大食品 (00834) announced that its shares will be temporarily suspended from trading starting at 9:00 AM on October 20, 2025 [1] Company Summary - 康大食品's shares will experience a trading halt, indicating a significant event or development that may impact the company's operations or market perception [1]

Core Viewpoint - Kangda Foods (00834) has announced a temporary suspension of its shares trading on the Hong Kong Stock Exchange starting from 9:00 AM on October 20, 2025, due to the pending release of an announcement containing insider information [1] Summary by Sections - **Trading Suspension** - The company's shares will be temporarily suspended from trading on the Hong Kong Stock Exchange on October 20, 2025, at 9:00 AM [1] - Following the public holiday in Singapore on October 20, 2025, the shares will also be suspended from trading on the Singapore Stock Exchange starting from 9:00 AM on October 21, 2025 [1]